| Analysis | Metabolite Name | Measured Value | Units | Strain | Treatment |
|---|---|---|---|---|---|
| GCMS (Liver) | FA(16:0) | 9743790 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 10498868 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 11502077 | Peak area | AHR -/- | Control |
| GCMS (Liver) | FA(16:0) | 11510080 | Peak area | AHR -/- | Control |
| GCMS (Liver) | FA(16:0) | 12049414 | Peak area | AHR -/- | Control |
| GCMS (Liver) | FA(16:0) | 12080169 | Peak area | WT | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 12582869 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 12739530 | Peak area | WT | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 13418382 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 13560441 | Peak area | WT | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 13700083 | Peak area | WT | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 13877611 | Peak area | WT | Control |
| GCMS (Liver) | FA(16:0) | 14904496 | Peak area | AHR -/- | Control |
| GCMS (Liver) | FA(16:0) | 14975285 | Peak area | AHR -/- | Control |
| GCMS (Liver) | FA(16:0) | 16590918 | Peak area | WT | Control |
| GCMS (Liver) | FA(16:0) | 16712954 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Liver) | FA(16:0) | 17132619 | Peak area | WT | Control |
| GCMS (Liver) | FA(16:0) | 17336783 | Peak area | WT | Control |
| GCMS (Liver) | FA(16:0) | 18503292 | Peak area | WT | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 3509033 | Peak area | WT | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 3881753 | Peak area | WT | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 4498282 | Peak area | WT | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 4790589 | Peak area | WT | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 4990965 | Peak area | WT | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 5102105 | Peak area | AHR -/- | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 5115495 | Peak area | WT | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 5565339 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 5801504 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 5849114 | Peak area | AHR -/- | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 6101449 | Peak area | AHR -/- | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 6270519 | Peak area | WT | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 6397721 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 6463901 | Peak area | AHR -/- | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 6519217 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 6535835 | Peak area | AHR -/- | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 6839948 | Peak area | AHR -/- | TCDF Treatment |
| GCMS (Serum fatty acids) | FA(16:0) | 7043406 | Peak area | WT | Control |
| GCMS (Serum fatty acids) | FA(16:0) | 8136341 | Peak area | WT | Control |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|